L&T Mindtree Stock: Buy, Sell, Hold – here’s what brokerages say about it, check their target

LTI Mindtree (LTIM) has drawn mixed reactions from brokerages following its recent performance. While some analysts maintain a positive outlook, citing strong deal momentum and broad-based growth, others remain cautious with a bearish stance. Here’s a breakdown of what brokerages suggest for LTIM stock:

Brokerage Ratings and Targets

Advertisement

  • Macquarie: Maintains an ‘Outperform’ rating with a target price of ₹7,100, citing record deal wins and robust client growth across sectors.
  • Morgan Stanley (MS): Retains an ‘Overweight’ stance with a target price of ₹6,800, emphasizing LTIM’s ability to recover medium-term growth despite near-term margin pressures.
  • Citi: Maintains a ‘Sell’ call, lowering the target price to ₹5,375 (from ₹5,700), reflecting concerns over slow margin recovery and headwinds from macroeconomic conditions.
  • Nomura: Continues with a ‘Sell’ rating, reducing the target price to ₹5,070, highlighting near-term challenges due to productivity benefit pass-through and slow margin recovery.

Market Performance

LTIM’s current market price stands at ₹5,987.60, offering a potential upside of up to 18.6% based on the highest target price of ₹7,100 from Macquarie. Conversely, Citi and Nomura predict a downside, aligning with their cautious outlooks.

Key Highlights

  • Positive sentiment from Macquarie and Morgan Stanley is driven by strong client traction and robust deal wins.
  • Citi and Nomura remain cautious, pointing to concerns over near-term growth headwinds and slow margin recovery.
  • Management’s commentary on improving demand and long-term growth strategies will be closely watched.

Conclusion

With a mix of bullish and bearish views, LTI Mindtree presents a divided outlook for investors. Long-term growth potential highlighted by Macquarie and MS may appeal to optimistic investors, while risks flagged by Citi and Nomura suggest caution for those with a conservative approach.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors are advised to consult their financial advisors before making any investment decisions.